Skip to content

Viemed Healthcare, Inc. VMD Free cash flow margin

Free cash flow margin at other companies

AdaptHealth logo
AdaptHealthAHCO
5.8%-2.6pp
The Pennant Group, Inc. logo
The Pennant Group, Inc.PNTG
5%+3.7pp
ResMed logo
ResMedRMD
31.7%+0.4pp
UFP Technologies logo
UFP TechnologiesUFPT
12.3%+2.0pp
Merit Medical Systems logo
Merit Medical SystemsMMSI
14.3%+1.3pp
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
3%

Other financials

Income statement

See full
Revenue$75.4M+27.5%
Gross profit$42.8M+28.7%
Operating income$4.3M+11.8%
Net income$2.6M-1.6%
EPS (diluted)$0.060.0%

Balance sheet

See full
Cash & equivalents$9.8M-3.9%
Total debt$12.4M+84.0%
Total equity$143.9M+6.8%
Total assets$197.4M+10.8%

Cash flow

See full
Operating cash flow$8.1M+183%
CapEx$6.7M-56.6%
Free cash flow$1.4M+111%

Valuation

See full
Market cap$448.16M+71.3%
Enterprise value$450.83M+74.6%
P/E30.1×+8.8×
P/S1.6×+0.4×

Profitability

See full
Gross margin57.6%-1.1pp
Operating margin8.2%-0.2pp
Net margin5.2%-0.1pp

Returns & leverage

See full
Return on equity10.7%+0.9pp
Debt / equity0.1×0.0×
Current ratio1.2×-0.2×

Where this comes from

Calculated from Viemed Healthcare, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Viemed Healthcare, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Viemed Healthcare, Inc.'s free cash flow margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Viemed Healthcare, Inc.'s free cash flow margin?
Viemed Healthcare, Inc. (VMD) reported free cash flow margin of 9% in Q1 2026.
What is the long-term trend for Viemed Healthcare, Inc.'s free cash flow margin?
Over 2 years (2020 to 2025), Viemed Healthcare, Inc.'s free cash flow margin has grown at a -48.7% compound annual growth rate (CAGR), from 16.8% to 4.4%.
What does free cash flow margin mean?
Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.